Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2000
12/20/2000EP1060251A2 Phosphodiesterase 10
12/20/2000EP1060192A2 Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
12/20/2000EP1060190A1 New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphtyl)ethyl)amide
12/20/2000EP1060182A2 Novel prodrugs for phosphorus-containing compounds
12/20/2000EP1060175A2 Tryptase inhibitors
12/20/2000EP1060173A2 Benzazine derivatives phosphodiesterase 4 inhibitors
12/20/2000EP1060171A2 Tryptase inhibitors
12/20/2000EP1060169A1 1,4-diazacycloheptane derivatives
12/20/2000EP1060168A2 Method for preparing sulfanyl-type endothelin receptor antagonists
12/20/2000EP1060167A1 Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed et a?/et b?-receptor antagonists
12/20/2000EP1060164A1 Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists
12/20/2000EP1060163A1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
12/20/2000EP1060162A1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors
12/20/2000EP1060161A1 Matrix metalloproteinase inhibitors
12/20/2000EP1059937A2 Il-12 enhancement of immune responses to t-independent antigens
12/20/2000EP1059931A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
12/20/2000EP1059930A1 Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid
12/20/2000EP1059929A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/20/2000EP1059927A1 Chemical compounds and their use to elevate pyruvate dehydrogenase activity
12/20/2000EP1059925A1 Ep2-receptor agonists as neuroprotective agents for the eye
12/20/2000EP1059923A1 Combination of a selective nmda nr2b antagonist and an opioid analgesic
12/20/2000EP1059922A2 Glycine transport inhibitors
12/20/2000EP1059921A2 Use of macrolide compounds for the treatment of ards
12/20/2000EP1059920A1 Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis
12/20/2000EP1059919A1 Small molecules that increase the conversion of food to body weight gain
12/20/2000EP1059889A1 Treatment of brain edema using carbonic anhydrase enzyme inhibitor
12/20/2000EP1059843A1 Method for decreasing qt dispersion or inhibiting the progression of qt dispersion with an angiotensin ii receptor antagonist
12/20/2000EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor
12/20/2000EP0788352B1 Treatment of animals
12/20/2000EP0753526B1 Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient
12/20/2000EP0726898B1 Phenylindole compounds
12/20/2000EP0700378B1 Compounds which release nitric oxide
12/20/2000EP0671934B1 Method of treating cell damage or depletion
12/20/2000EP0543858B1 Benzimidazole derivatives, process for their preparation and application
12/20/2000CN1277636A High efficiency vetroviral rectors that contain none of viral coding sequences
12/20/2000CN1277613A Poly (ADP-ribose) polymerase ('PARP') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
12/20/2000CN1277611A 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
12/20/2000CN1277607A 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-HT1A, 5-HT1b and 5-HT1D)
12/20/2000CN1277605A Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors
12/20/2000CN1277198A New bicyclo aminopyrazineone compound, its producing process and medical composition containing them
12/20/2000CN1277194A New 1- aza-2-alkyl-6-aryl-cyclanes compound, its producing process and medical composition containing them
12/20/2000CN1277044A Preparation of serial healthy foods with peach blossom, pearl and ant
12/20/2000CN1277040A Oxygen-making up and stamina-strenthening liquid
12/20/2000CN1277019A Medicament for intensifing brain acetylcholine releasing
12/20/2000CN1059591C Hair-care medicine for making hair black and its preparing method
12/20/2000CN1059588C Chinese herbal medicine for strengthening yang
12/20/2000CN1059570C Medicine for curing enuresis
12/19/2000US6162830 Antihistamines, antiallergens, bone disorders
12/19/2000US6162829 (3R,4R)-Δ8 -tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics
12/19/2000US6162819 Pyrazole derivatives, their preparation and their use in pharmaceuticals
12/19/2000US6162817 Stroke therapy; brain disorders; crohn's disease
12/19/2000US6162812 Pharmaceutical compositions containing HIV protease inhibitors and methods of their use
12/19/2000US6162805 Use of an NK-1 receptor antagonist and an SSRI for treating obesity
12/19/2000US6162800 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors
12/19/2000US6162798 Cerebrovascular contraction after subarachnoid hemorrhage with quinoline compounds
12/19/2000US6162796 Method for transferring genes to the heart using AAV vectors
12/19/2000US6162791 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
12/19/2000US6162790 Oligopeptides
12/19/2000US6162629 Preparing a serine protease solution; eluting protease from column, freeze drying, filtering and recovering protease
12/19/2000US6162444 Cosmetic or pharmaceutical compositions
12/19/2000US6162435 A isolated protein for treating swine; a diagnostic test kit for detecting the presence of bacterial infection in swine herds
12/19/2000US6162427 Treating tumor by administering colony stimulating factor
12/19/2000US6161536 Dosage form for aerosol administration
12/19/2000CA2050291C Combination therapy for the treatment of estrogen sensitive diseases
12/19/2000CA2028629C Antiandrogenically-effective pharmaceutical compositions
12/19/2000CA2001225C Antimicrobial lactam-quinolones
12/19/2000CA2000420C Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof
12/14/2000WO2000075365A2 Compounds and methods to enhance raav transduction
12/14/2000WO2000075339A1 Substrate trapping protein tyrosine phosphatases
12/14/2000WO2000075334A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000WO2000075328A1 Human sel-10 polypeptides and polynucleotides that encode them
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075278A2 Gene encoding nade, p75ntr-associated cell death executor and uses thereof
12/14/2000WO2000075187A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000WO2000075186A1 Neuromedin b and somatostatin receptor agonists
12/14/2000WO2000075184A1 Modulation of protein levels using the scf complex
12/14/2000WO2000075176A1 Small cyclic mimics of brain-derived neurotrophic factor (bdnf)
12/14/2000WO2000075172A2 FACTOR VIIa INHIBITORS
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075150A1 Ip3 receptor ligands
12/14/2000WO2000075144A2 Peroxynitrite decomposition catalysts and methods of use thereof
12/14/2000WO2000075142A2 Dna methyltransferase inhibitors
12/14/2000WO2000075140A1 7-oxo-2-azabicyclo[2.2.1]heptanes as selective muscarinic receptor antagonist
12/14/2000WO2000075139A2 Benzothiazinone and benzoxazinone compounds
12/14/2000WO2000075134A1 Pyrazinone thrombin inhibitors
12/14/2000WO2000075131A1 Substituted pyrazole compounds
12/14/2000WO2000075123A1 Substituted 5-oxo-5,6,7,8-tetrahydro-4h-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of ampa
12/14/2000WO2000075121A2 Process for preparing 10,11-methanobenzosuberane derivatives
12/14/2000WO2000075120A1 Diaminothiazoles and their use for inhibiting protein kinases
12/14/2000WO2000075117A1 Compositions and methods for inhibiting cell death
12/14/2000WO2000075114A1 Beta2-adrenoceptor agonists
12/14/2000WO2000075113A1 Novel heterocyclic carboxamide derivatives
12/14/2000WO2000075110A1 Pharmaceutical compositions and methods for use
12/14/2000WO2000075108A1 Inhibitors of metalloproteinases
12/14/2000WO2000075107A2 Bradykinin receptor antagonists
12/14/2000WO2000074725A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074722A2 Modification of biological elements
12/14/2000WO2000074721A1 Vitamin directed dual targeting therapy
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
1 ... 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 ... 1564